Overview

A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of LY3549492 in adults with obesity or overweight. Participation in the study will last about one year.
Phase:
PHASE2
Details
Lead Sponsor:
Eli Lilly and Company